News
OGEN
--
0.00%
--
10-Q: ORAGENICS INC
(EDGAR Online via COMTEX) -- ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS The following information should...
Edgar Online - (EDG = 10Q, 10K) · 3d ago
BRIEF-Oragenics Announce Changes In Management And Board Of Directors
reuters.com · 4d ago
Oragenics Says Board Will Provide Direction to Co in Interim
Oragenics Says Board Will Provide Direction to Co in Interim
Dow Jones · 4d ago
Oragenics Says Sullivan to Serve as Interim Principal Executive Officer >OGEN
Oragenics Says Sullivan to Serve as Interim Principal Executive Officer >OGEN
Dow Jones · 4d ago
Oragenics: Frederick Telling Transitioning From Chmn to Newly Established Position of Executive Chmn >OGEN
Oragenics: Frederick Telling Transitioning From Chmn to Newly Established Position of Executive Chmn >OGEN
Dow Jones · 4d ago
Oragenics Announce Changes in Management and Board of Directors
BusinessWire - BZX · 4d ago
Oragenics Says Alan Joslyn Resigned as Chief Executive Officer, Pres and Director >OGEN
Oragenics Says Alan Joslyn Resigned as Chief Executive Officer, Pres and Director >OGEN
Dow Jones · 4d ago
OGEN: COVID-19 Vaccine Candidate Exhibits Protective Immunity in Mice…
By David Bautz, PhD NYSE:OGEN READ THE FULL OGEN RESEARCH REPORT
Benzinga · 04/14 14:31
OGEN: COVID-19 Vaccine Candidate Exhibits Protective Immunity in Mice
By David Bautz, PhD NYSE:OGEN READ THE FULL OGEN RESEARCH REPORT Business Update CoV-2 S-2P Demonstrates Protective Immunity in Mice In February 2021, Oragenics, Inc. (NYSE:OGEN) announced data from the National Institutes of Health (NIH) that demonstrated...
Zacks Small Cap Research · 04/09 15:50
8-K: ORAGENICS INC
Edgar Online - (EDK = 8-Ks/S1/S-4) · 04/01 21:51
Enveric Biosciences, MediciNova leads healthcare gainers; INVO Bioscience, Second Sight Medical Products among major losers
Gainers: Enveric Biosciences ENVB +86%, MediciNova (MNOV) +53%, Artelo Biosciences ARTL +23%, Inari Medical (NARI) +15%.Losers: INVO Bioscience (INVO) -34%, Second Sight Medical Products (EYES) -26%, Sintx Technologies (SINT) -23%, Auris Medical (EARS) -21...
Seekingalpha · 03/10 16:00
Tupperware Brands, Oragenics leads the premarket losers' pack
Sundance Energy (SNDE) -42% on filing for voluntary Chapter 11 protection to strengthen balance sheet and position business for sustained future success, commences financial restructuring with lender support.INVO Bioscience (INVO) -17%.Tupperware
Seekingalpha · 03/10 13:34
DJ Oragenics Shares Rise 43% on Material Transfer Deal for Covid-19 Vaccine
Dow Jones · 03/09 18:02
RIOT, SFIX, WPG and ACAD among midday movers
Gainers: Exela Technologies (XELA) +163%.Oragenics (OGEN) +47%.ReneSola (SOL) +42%.Auris Medical (EARS) +39%.The9 (NCTY) +37%.Canaan (CAN) +36%.AnPac Bio-Medical Science (ANPC) +36%.Riot Blockchain (RIOT) +35%.Washington Prime (WPG) +30%.Socket Mobile (SCK...
Seekingalpha · 03/09 17:41
Oragenics' COVID-19 Related Deal Pushes The Stock Higher
Oragenics Inc (NYSE: OGEN) stock is soaring higher after 
Benzinga · 03/09 17:10
Oragenics inks material transfer agreement for COVID-19 vaccine adjuvants
Oragenics ([[OGEN]] +38.5%) announces that it has entered into a material transfer agreement with Biodextris for the use of three intranasal mucosal adjuvants in the company’s Terra CoV-2 vaccine against COVID-19.The initial
Seekingalpha · 03/09 16:41
Best Biotech Penny Stocks To Watch Before Friday
Mar 09, 2021 (Penny Stocks via COMTEX) -- Biotech Penny Stocks To Watch Right Now While penny stocks are well-known for volatility, so too are certain...
Penny Stocks · 03/09 14:28
DJ Oragenics in Material Transfer Agreement With Biodextris for Covid-19 Vaccine
Dow Jones · 03/09 12:24
Oragenics Enters into Material Transfer Agreement With Biodextris For The Use Of Mucosal Adjuvant In Its Intranasal COVID-19 Vaccine; Financial Details Not Disclosed
Oragenics, Inc. (NYSE:OGEN) ("Oragenics" or the "Company") announced it has entered into a material transfer agreement with Biodextris Inc. for the use of three intranasal mucosal adjuvants in
Benzinga · 03/09 12:02
Webull provides a variety of real-time OGEN stock news. You can receive the latest news about ORAGENICS through multiple platforms. This information may help you make smarter investment decisions.
About OGEN
Oragenics, Inc. is a healthcare company. The Company is focused on developing treatments for oral mucositis and novel antibiotics against infectious disease. The Company is focused on developing of the TerraCoV2 immunization product candidate. The Company’s product candidate includes, OG716, as an antibiotic, as well as other homolog antibiotic product candidates and AG013 for the treatment of oral mucositis in patients undergoing treatment for cancer. The Company have developed other product such as weight loss candidate, LPT3-04 and SMaRT Replacement Therapy.